Bank of New York Mellon
CAI

Bank of New York Mellon’s Caris Life Sciences CAI Stock Holding History

Bank of New York Mellon’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.5M Buy
308,407
+76,746
+33% +$1.37M ﹤0.01% 2391
2026
Q1 		$4.14M Buy
231,661
+181,258
+360% +$3.96M ﹤0.01% 2424
2025
Q4 		$1.36M Buy
50,403
+25,534
+103% +$719K ﹤0.01% 3069
2025
Q3 		$752K Buy
+24,869
New +$793K ﹤0.01% 3371

Other funds holding CAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Bank of New York Mellon's CAI Position: Q2 2026 in Review

Bank of New York Mellon increased its Caris Life Sciences (CAI) stake by 33% in Q2 2026, buying an estimated $1.37M and bringing the position to 308,407 shares worth $5.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2391.

Bank of New York Mellon first reported a position in CAI in Q3 2025 and has held it in 4 quarters since. 106 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Bank of New York Mellon held 308,407 shares of Caris Life Sciences worth $5.5M as of Q2 2026.
  • Bank of New York Mellon bought 76,746 Caris Life Sciences shares in Q2 2026, an estimated $1.37M.
  • Caris Life Sciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2391 holding.
  • Bank of New York Mellon first reported a position in Caris Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 106 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.